About Rhesus Disease
Rhesus disease, also known as Rh D alloimmunization or hemolytic disease of the fetus and newborn, is a condition that occurs when a pregnant person with Rh negative blood type is exposed to Rh positive blood from their baby. This can happen during pregnancy or childbirth.
When the mother's immune system detects the Rh-positive blood, it may produce antibodies against the baby's red blood cells. These antibodies can cross the placenta and attack the baby's red blood cells, leading to anemia and other complications.
Rhesus disease can result in serious health problems for the baby, including jaundice, anemia, and even fetal death. However, with proper medical care and preventive measures, such as Rh immunoprophylaxis (RhIg), the risk of Rhesus disease can be greatly reduced.
RhIg is a medication that is given to Rh negative pregnant individuals to prevent them from developing antibodies against Rh positive blood. It works by suppressing the immune response and preventing sensitization to the Rh-D antigen. By administering RhIg after delivery of a Rh-positive baby, the risk of sensitization can be reduced significantly.
Overall, Rhesus disease is a preventable condition that can have serious consequences for both the mother and the baby. It highlights the importance of prenatal care and proper management for individuals with Rh negative blood type during pregnancy and childbirth.
Rhesus disease, also known as hemolytic disease of the newborn, is caused when a mother’s Rh-negative blood containing Rh factor antibodies mixes with a newborn’s Rh-positive blood. The antibodies attack the Rh factor on the baby’s red blood cells, leading to the destruction of red blood cells in the fetus or newborn.
Risk factors for Rhesus disease include:
- Inherited blood types: If a mother has a negative blood type (such as O negative) and the father has a positive blood type (such as A positive), there is a chance that their baby may inherit positive blood type and Rhesus antigens from the father. This can increase the risk of Rhesus disease if the mother's immune system becomes sensitized to these antigens.
- Blood transfusions: If a person receives a blood transfusion that is not compatible with their own blood type, it can lead to the development of Rhesus antibodies in their immune system. This can increase the risk of Rhesus disease in future pregnancies.
- Pregnancy complications: Certain complications during pregnancy, such as miscarriage, ectopic pregnancy, or invasive procedures like amniocentesis or chorionic villus sampling, can increase the risk of sensitization to Rhesus antigens and subsequent development of Rhesus disease.
In the newborn, symptoms of Rhesus (Rh) disease include:
- Jaundice (yellow whites of eyes or skin)
- Fast heart rate
- Fast breathing
- Swollen abdomen
- Low muscle tone
To diagnose Rhesus disease, doctors may perform the following examinations, tests, and procedures:
- Newborn examination: A standardized examination is conducted to identify any abnormal findings on the surface of the newborn's body. This includes checking the heart and lungs through auscultation, which means listening to their sounds using a stethoscope.
- Medical confirmation: If any abnormalities are suspected during the newborn examination, a medical doctor will confirm the findings.
- Rhesus testing: In some cases, Rhesus testing may be performed.
- ABO incompatibility consideration: For newborns of blood groups A or B born to mothers of blood group O, potential ABO incompatibility is considered.
Additional examinations, tests, and procedures may be performed, including:
- Ultrasound to check for enlarged organs or fluid build-up in the baby
During pregnancy, Rhesus disease can be diagnosed through amniocentesis and fetal blood sampling from the umbilical cord.
The goals of treatment for Rhesus disease, also known as Rh disease or Rh incompatibility, are to prevent complications and ensure the health and well-being of both the mother and the baby. Here are the different types of treatments and interventions that are recommended to achieve these goals:
Medications:
- Rh immunoglobulin (RhIg): This medication is given to Rh-negative mothers during pregnancy and after delivery. It works by preventing the mother's immune system from producing antibodies against the Rh factor in the baby's blood, thus reducing the risk of complications.
Therapies and therapeutic procedures:
- Amniocentesis: This procedure involves removing a small amount of amniotic fluid from around the baby in the womb. It helps determine if the baby has developed any complications due to Rh incompatibility.
- Intrauterine transfusion: In severe cases, when the baby's blood is affected by Rh antibodies, this procedure can be performed to transfuse compatible blood directly into the baby's umbilical cord.
Health behavior changes:
- Regular prenatal care: It is important for pregnant individuals to receive regular check-ups throughout their pregnancy to monitor the baby's health and identify any potential issues related to Rh incompatibility.
- Avoidance of sensitizing events: Pregnant individuals should avoid activities that may cause bleeding, such as trauma or invasive medical procedures, as these can increase the risk of sensitization.
Other treatments:
- Fetal monitoring: Regular monitoring of the baby's heart rate and movement helps detect any signs of distress or complications.
- Early delivery: In some cases, if there is a risk to the baby's health, early delivery may be recommended to ensure prompt medical intervention.
By implementing these treatments and interventions, healthcare providers aim to prevent complications associated with Rhesus disease. Rh immunoglobulin helps prevent sensitization in Rh-negative mothers, while amniocentesis and intrauterine transfusion allow for monitoring and intervention if needed. Regular prenatal care, avoidance of sensitizing events, fetal monitoring, and early delivery all contribute to ensuring the health and well-being of both mother and baby throughout pregnancy.
The natural progression of Rhesus disease (RD) over time can vary depending on the stage of the disease. Complications that may occur from RD include:
- Anemia: If anemia is severe, the liver and spleen may enlarge.
- Jaundice: Yellowing of skin, eyes, and mucous membranes
- Kernicterus: A neurological condition caused by bilirubin build-up in the brain.
- Heart failure due to fluid building up in the fetal tissues.